Cancer cell migration and cancer drug screening in oxygen tension gradient chip.
Journal
Biomicrofluidics
ISSN: 1932-1058
Titre abrégé: Biomicrofluidics
Pays: United States
ID NLM: 101293825
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
21
04
2020
accepted:
28
06
2020
entrez:
4
8
2020
pubmed:
4
8
2020
medline:
4
8
2020
Statut:
epublish
Résumé
Cancer metastasis, which is prevalent in malignant tumors, is present in a variety of cases depending on the primary tumor and metastatic site. The cancer metastasis is affected by various factors that surround and constitute a tumor microenvironment. One of the several factors, oxygen tension, can affect cancer cells and induce changes in many ways, including motility, directionality, and viability. In particular, the oxygen tension gradient is formed within a tumor cluster and oxygen is lower toward the center of the cluster from the perivascular area. The simple and efficient designing of the tumor microenvironment using microfluidic devices enables the simplified and robust platform of the complex
Identifiants
pubmed: 32742536
doi: 10.1063/5.0011216
pii: 5.0011216
pmc: PMC7375834
doi:
Types de publication
Journal Article
Langues
eng
Pagination
044107Informations de copyright
Copyright © 2020 Author(s).
Références
Curr Cancer Drug Targets. 2003 Dec;3(6):391-405
pubmed: 14683498
Nat Rev Drug Discov. 2003 Oct;2(10):803-11
pubmed: 14526383
Nat Rev Drug Discov. 2016 May 3;15(5):299
pubmed: 27139987
Lab Chip. 2014 Dec 21;14(24):4688-95
pubmed: 25315003
J Natl Cancer Inst. 2011 Jan 19;103(2):117-28
pubmed: 21228314
Integr Biol (Camb). 2014 Jun;6(6):603-10
pubmed: 24763498
Lab Chip. 2013 Feb 21;13(4):695-705
pubmed: 23254684
Br J Cancer. 1981 Aug;44(2):241-6
pubmed: 7272189
Lab Chip. 2014 Oct 7;14(19):3762-72
pubmed: 25096368
Lab Chip. 2009 Apr 21;9(8):1073-84
pubmed: 19350089
Breast Cancer Res. 2013 Jan 07;15(1):R2
pubmed: 23294542
Cancer Metastasis Rev. 2001;20(1-2):123-32
pubmed: 11831640
J Cell Sci. 2012 Dec 1;125(Pt 23):5591-6
pubmed: 23420197
Nat Med. 1997 Feb;3(2):177-82
pubmed: 9018236
Nature. 2006 May 25;441(7092):437-43
pubmed: 16724055
Lab Chip. 2010 Feb 7;10(3):388-91
pubmed: 20091013
Cancer Res. 1989 Dec 1;49(23):6449-65
pubmed: 2684393
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11115-20
pubmed: 21690404
Arch Pathol Lab Med. 2008 Jun;132(6):931-9
pubmed: 18517275
Oncol Rep. 2015 Apr;33(4):1837-43
pubmed: 25634491
Nat Med. 2009 Oct;15(10):1219-23
pubmed: 19749772
Cancer Res. 1999 Nov 1;59(21):5475-8
pubmed: 10554021
Br J Cancer. 2010 Jan 19;102(2):351-60
pubmed: 20010940
J Cell Sci. 2012 Jul 1;125(Pt 13):3015-24
pubmed: 22797912
J Cell Sci. 2009 Apr 15;122(Pt 8):1055-7
pubmed: 19339544
Nucleic Acids Res. 2000 May 15;28(10):2135-40
pubmed: 10773083
Trends Biotechnol. 2014 Nov;32(11):556-563
pubmed: 25282035
J Biol Chem. 2013 Apr 12;288(15):10819-29
pubmed: 23423382
Nat Rev Drug Discov. 2006 Sep;5(9):741-54
pubmed: 16915232
Lab Chip. 2011 Nov 7;11(21):3626-33
pubmed: 21915399
Biophys J. 2018 Nov 20;115(10):2034-2043
pubmed: 30366624
Exp Cell Res. 2013 Feb 15;319(4):487-97
pubmed: 23153553
Lab Chip. 2013 Aug 21;13(16):3239-45
pubmed: 23784347
Biomaterials. 2015 Jun;52:262-71
pubmed: 25818432
Drug Discov Today. 2012 Feb;17(3-4):173-81
pubmed: 22094245
Oncogenesis. 2018 Jan 24;7(1):10
pubmed: 29362402
Mol Cancer Ther. 2006 Aug;5(8):2115-20
pubmed: 16928833
Clin Cancer Res. 2010 Dec 15;16(24):5928-35
pubmed: 20962028
Dis Model Mech. 2017 Sep 1;10(9):1061-1074
pubmed: 28883015
Lab Chip. 2012 Nov 21;12(22):4855-63
pubmed: 23023115
Cancer Res. 2005 Apr 1;65(7):2761-9
pubmed: 15805276
Cancer Res. 2001 Dec 15;61(24):8903-8
pubmed: 11751415
APL Bioeng. 2020 Mar 06;4(1):016106
pubmed: 32161836
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10889-94
pubmed: 16832052